Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ifosfamide in experimental tumor systems.

× No keyword cloud information.

26 in total

Review 1. Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Authors: K L Dechant; R N Brogden; T Pilkington; D Faulds
Journal: Drugs Date: 1991-09 Impact factor: 9.546

2. Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin's lymphoma: a consortium for improving survival of lymphoma (CISL) trial.

Authors: Byeong-Bae Park; Won Seog Kim; Hyeon Seok Eom; Jin Seok Kim; Young Yiul Lee; Suk Joong Oh; Dae Ho Lee; Cheolwon Suh
Journal: Invest New Drugs Date: 2009-09-16 Impact factor: 3.850

3. 6-Day continuous infusion of high-dose ifosfamide with bone marrow growth factors in advanced refractory malignancies.

Authors: E C Brain; A Mita; P Soulié; H Errihani; A C Hardy Bessard; M Chaouche; J Alexandre; J P Delord; E Cvitkovic; C Jasmin; J L Misset
Journal: J Cancer Res Clin Oncol Date: 1997 Impact factor: 4.553

10. Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibility.

Authors: T Cerny; A Graf; P Rohner; T Zeugin; K W Brunner; A Küpfer
Journal: J Cancer Res Clin Oncol Date: 1991 Impact factor: 4.553

Ifosfamide in experimental tumor systems.

Review 1. Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

2. Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin's lymphoma: a consortium for improving survival of lymphoma (CISL) trial.

3. 6-Day continuous infusion of high-dose ifosfamide with bone marrow growth factors in advanced refractory malignancies.

4. Ifosfamide/etoposide and mesna uroprotection in advanced breast cancer.

5. High-dose ifosfamide and mesna in advanced breast cancer. A phase II study.

6. Phase I study of high-dose cisplatin, ifosfamide, and etoposide.

7. Cisplatin-ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous-cell carcinoma.

8. Treatment of gynecological malignancies with a combination of cisplatin, adriamycin and ifosfamide.

9. Ifosfamide + mitoxantrone in advanced breast cancer previously treated with anthracyclines.

10. Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibility.